The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of a large language model (LLM) for pan-cancer automated detection of anti-cancer therapy toxicities and translational toxicity research.
 
Ziad Bakouny
Honoraria - UpToDate
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
(OPTIONAL) Uncompensated Relationships - ASCO IMG Community of Practice; Dana-Farber Cancer Institute; IMG Oncologists (NGO)
 
Nishat Ahmed
No Relationships to Disclose
 
Christopher Fong
No Relationships to Disclose
 
Afsana Rahman
No Relationships to Disclose
 
Tomin Perea-Chamblee
No Relationships to Disclose
 
Karl Pichotta
No Relationships to Disclose
 
Michele Waters
No Relationships to Disclose
 
Chenlian Fu
No Relationships to Disclose
 
Mark Jeng
No Relationships to Disclose
 
Mindy Lee
No Relationships to Disclose
 
Chris Marotta
No Relationships to Disclose
 
Neil Shah
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Merck Sharp & Dohme Corp.
Research Funding - Aravive (Inst); Exelixis; HiberCell (Inst)
Travel, Accommodations, Expenses - Merck
 
Nikolaus Schultz
Honoraria - OneOncology
 
Adam Schoenfeld
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Enara Bio; Heat Biologics; Immunocore; Iovance Biotherapeutics; Johnson & Johnson/Janssen; KSQ Therapeutics; Legend Biotech; Lyell Immunopharma; Merck; Oppenheimer; Perceptive Advisors; Prelude Therapeutics; Umoja Biopharma
Research Funding - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
Travel, Accommodations, Expenses - Instil Bio; Iovance Biotherapeutics
Other Relationship - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
 
Robert Motzer
Consulting or Advisory Role - Aveo; EMD Serono; Exelixis; Incyte; Merck; Takeda
Research Funding - Aveo (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Justin Jee
No Relationships to Disclose
 
Craig Thompson
Leadership - Charles River Laboratories; Regeneron
Stock and Other Ownership Interests - Charles River Laboratories; Regeneron
Patents, Royalties, Other Intellectual Property - Elsevier
 
Jian Carrot-Zhang
No Relationships to Disclose
 
Eduard Reznik
No Relationships to Disclose
 
MSK Cancer Data Science Initiative (CDSI)
No Relationships to Disclose